Literature DB >> 31378912

Hypoxic preconditioning BMSCs-exosomes inhibit cardiomyocyte apoptosis after acute myocardial infarction by upregulating microRNA-24.

C-S Zhang1, K Shao, C-W Liu, C-J Li, B-T Yu.   

Abstract

OBJECTIVE: To elucidate the regulatory effect of hypoxic preconditioning bone marrow mesenchymal stem cells (BMSCs)-exosomes on cardiomyocyte apoptosis in acute myocardial infarction (AMI) rats.
MATERIALS AND METHODS: BMSCs-derived exosomes were extracted by Exoquick method. Expressions of exosome surface markers were determined by Western blot. The AMI model in rats was established by LAD ligation. Rats were randomly assigned into sham group, AMI group, AMI+H-exo group and AMI+N-exo group. MicroRNA-24 expression in rat myocardium was detected at different time points. Subsequently, hypoxic preconditioning or normoxic preconditioning BMSCs-exosomes were intramyocardially injected into rats. Infarct size was calculated through TTC (triphenyltetrazolium chloride) staining. Cardiomyocyte apoptosis was accessed with Terminal Deoxynucleotidyl Transferase dUTP Nick-end Labeling (TUNEL). Heart function of AMI rats was evaluated by echocardiography. Protein expressions of apoptotic genes in rat myocardium were detected by Western blot.
RESULTS: The mRNA level of microRNA-24 was higher in H-exo group than N-exo group. Injection of hypoxic preconditioning BMSCs-exosomes markedly upregulated microRNA-24 level, reduced infarct size and improved cardiac function in AMI rats. Protein expressions of Bax, caspase-3 and cleaved-caspase-3 were downregulated by BMSCs-exosomes treatment. H9c2 cells showed upregulated microRNA-24 level and decreased apoptotic rate after incubation with hypoxic preconditioning BMSCs-exosomes. The above cellular performances were partially reversed by transfection of microRNA-24 inhibitor.
CONCLUSIONS: Hypoxic preconditioning BMSCs-exosomes inhibit cardiomyocyte apoptosis in AMI rats by upregulating microRNA-24.

Entities:  

Year:  2019        PMID: 31378912     DOI: 10.26355/eurrev_201908_18560

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  19 in total

1.  Hypoxic Preconditioning Enhances the Efficacy of Mesenchymal Stem Cells-Derived Conditioned Medium in Switching Microglia toward Anti-inflammatory Polarization in Ischemia/Reperfusion.

Authors:  Han Yu; Zhihong Xu; Gaojing Qu; Huimin Wang; Lulu Lin; Xianyu Li; Xiaolin Xie; Yifeng Lei; Xiaohua He; Yun Chen; Yinping Li
Journal:  Cell Mol Neurobiol       Date:  2020-05-18       Impact factor: 5.046

Review 2.  New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases.

Authors:  Lamiaa Ahmed; Khaled Al-Massri
Journal:  Tissue Eng Regen Med       Date:  2022-07-22       Impact factor: 4.451

3.  Bone Marrow Mesenchymal Stem Cell-Derived Exosomal microRNA-29b-3p Promotes Angiogenesis and Ventricular Remodeling in Rats with Myocardial Infarction by Targeting ADAMTS16.

Authors:  Jialin Zheng; Xinjin Zhang; Wenfeng Cai; Yawei Yang; Tao Guo; Jianmei Li; Hualei Dai
Journal:  Cardiovasc Toxicol       Date:  2022-06-14       Impact factor: 2.755

Review 4.  Mesenchymal Stromal Cell Exosomes in Cardiac Repair.

Authors:  Darukeshwara Joladarashi; Raj Kishore
Journal:  Curr Cardiol Rep       Date:  2022-01-29       Impact factor: 3.955

Review 5.  Mesenchymal Stem Cell Exosomes in the Treatment of Myocardial Infarction: a Systematic Review of Preclinical In Vivo Studies.

Authors:  Hui Meng; Weiting Cheng; Lei Wang; Shiqi Chen; Yu Teng; Ziwen Lu; Yang Li; Mingjing Zhao
Journal:  J Cardiovasc Transl Res       Date:  2021-10-05       Impact factor: 3.216

6.  MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas.

Authors:  Rajshekhar A Kore; Xianwei Wang; Zufeng Ding; Robert J Griffin; Alan J Tackett; Jawahar L Mehta
Journal:  Mol Cell Biochem       Date:  2021-01-10       Impact factor: 3.396

Review 7.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

Review 8.  Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation.

Authors:  Marina O Gomzikova; Victoria James; Albert A Rizvanov
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

Review 9.  Novel Applications of Mesenchymal Stem Cell-derived Exosomes for Myocardial Infarction Therapeutics.

Authors:  Sho Joseph Ozaki Tan; Juliana Ferreria Floriano; Laura Nicastro; Costanza Emanueli; Francesco Catapano
Journal:  Biomolecules       Date:  2020-05-02

10.  Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis.

Authors:  Xi Liu; Feng Jiang; Zhilinag Wang; Lang Tang; Bin Zou; Pengfei Xu; Tenghua Yu
Journal:  J Cell Mol Med       Date:  2020-11-21       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.